Cargando…
Pharmacogenomics deliberations of 2-deoxy-d-glucose in the treatment of COVID-19 disease: an in silico approach
The outbreak of COVID-19 caused by the coronavirus (SARS-CoV-2) prompted number of computational and laboratory efforts to discover molecules against the virus entry or replication. Simultaneously, due to the availability of clinical information, drug-repurposing efforts led to the discovery of 2-de...
Autores principales: | Prabhu, Navya B., Vinay, Chigateri M., Satyamoorthy, Kapaettu, Rai, Padmalatha S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491670/ https://www.ncbi.nlm.nih.gov/pubmed/36164436 http://dx.doi.org/10.1007/s13205-022-03363-4 |
Ejemplares similares
-
Pharmacogenomic considerations for repurposing of dexamethasone as a potential drug against SARS-CoV-2 infection
por: Vohra, Manik, et al.
Publicado: (2021) -
Distinct metabolic signatures in blood plasma of bisphenol A–exposed women with polycystic ovarian syndrome
por: Prabhu, Navya B., et al.
Publicado: (2023) -
Effect of licorice on patients with HSD11B1 gene polymorphisms- a pilot study
por: Devang, Nayana, et al.
Publicado: (2021) -
Development of DNA markers using next-generation sequencing approach for molecular authentication of Boerhavia diffusa L. and Tinospora cordifolia (Willd.) Miers
por: Sharma, Anu Radha, et al.
Publicado: (2023) -
In vitro bioproduction and enhancement of moscatilin from a threatened tropical epiphytic orchid, Dendrobium ovatum (Willd.) Kraenzl
por: Pujari, Ipsita, et al.
Publicado: (2021)